Literature DB >> 18368558

Risk factors for ovarian cancer: an overview with emphasis on hormonal factors.

Fariba Salehi1, Lesley Dunfield, Karen P Phillips, Daniel Krewski, Barbara C Vanderhyden.   

Abstract

Ovarian cancer is the fifth most frequently occurring cancer among women and leading cause of gynecological cancer deaths in North America. Although the etiology of ovarian cancer is not clear, certain factors are implicated in the etiology of this disease, such as ovulation, gonadotropic and steroid hormones, germ cell depletion, oncogenes and tumor suppressor genes, growth factors, cytokines, and environmental agents. Family history of breast or ovarian cancer is a prominent risk factor for ovarian cancer, with 5-10% of ovarian cancers due to heritable risk. Reproductive factors such as age at menopause and infertility contribute to greater risk of ovarian cancer, whereas pregnancy, tubal ligation, and hysterectomy reduce risk. Oral contraceptive (OC) use has clearly been shown to be protective against ovarian cancer. In contrast, large epidemiologic studies found hormone replacement therapy (HRT) to be a greater risk factor for ovarian cancer. The marked influence of hormones and reproductive factors on ovarian cancer suggests that endocrine disrupters may impact risk; however, there is a notable lack of research in this area. Lifestyle factors such as cigarette smoking, obesity, and diet may affect ovarian cancer risk. Exposure to certain environmental agents such as talc, pesticides, and herbicides may increase risk of ovarian cancer; however, these studies are limited. Further research is needed to strengthen the database of information from which an assessment of environmental and toxicological risk factors for ovarian cancer can be made.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18368558     DOI: 10.1080/10937400701876095

Source DB:  PubMed          Journal:  J Toxicol Environ Health B Crit Rev        ISSN: 1093-7404            Impact factor:   6.393


  53 in total

1.  Modeling perimenopause in Sprague-Dawley rats by chemical manipulation of the transition to ovarian failure.

Authors:  Jennifer B Frye; Ashley L Lukefahr; Laura E Wright; Sam L Marion; Patricia B Hoyer; Janet L Funk
Journal:  Comp Med       Date:  2012-06       Impact factor: 0.982

2.  Total synthesis of the α-subunit of human glycoprotein hormones: toward fully synthetic homogeneous human follicle-stimulating hormone.

Authors:  Baptiste Aussedat; Bernhard Fasching; Eric Johnston; Neeraj Sane; Pavel Nagorny; Samuel J Danishefsky
Journal:  J Am Chem Soc       Date:  2012-02-06       Impact factor: 15.419

Review 3.  Reproductive hazards of space travel in women and men.

Authors:  Birendra Mishra; Ulrike Luderer
Journal:  Nat Rev Endocrinol       Date:  2019-10-14       Impact factor: 43.330

Review 4.  FDG-PET in gynaecological cancers: recent observations.

Authors:  Giovanni Lucignani
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-11       Impact factor: 9.236

5.  Unbalanced estrogen metabolism in ovarian cancer.

Authors:  Muhammad Zahid; Cheryl L Beseler; James B Hall; Tricia LeVan; Ercole L Cavalieri; Eleanor G Rogan
Journal:  Int J Cancer       Date:  2014-01-25       Impact factor: 7.396

6.  Recent progress in the diagnosis and treatment of ovarian cancer.

Authors:  Danijela Jelovac; Deborah K Armstrong
Journal:  CA Cancer J Clin       Date:  2011-04-26       Impact factor: 508.702

Review 7.  Estrogen signaling crosstalk: Implications for endocrine resistance in ovarian cancer.

Authors:  Jennifer R Ribeiro; Richard N Freiman
Journal:  J Steroid Biochem Mol Biol       Date:  2014-02-22       Impact factor: 4.292

8.  Long non-coding RNA SOX2OT promotes cell proliferation and motility in human ovarian cancer.

Authors:  Ling Han; Wei Zhang; Bingyi Zhang; Leyun Zhan
Journal:  Exp Ther Med       Date:  2017-12-12       Impact factor: 2.447

9.  In Utero Exposure to Benzo[a]pyrene Induces Ovarian Mutations at Doses That Deplete Ovarian Follicles in Mice.

Authors:  Ulrike Luderer; Matthew J Meier; Gregory W Lawson; Marc A Beal; Carole L Yauk; Francesco Marchetti
Journal:  Environ Mol Mutagen       Date:  2018-12-21       Impact factor: 3.216

10.  Attributable causes of breast cancer and ovarian cancer in china: reproductive factors, oral contraceptives and hormone replacement therapy.

Authors:  Li Li; Jia Ji; Jian-Bing Wang; Mayineur Niyazi; You-Lin Qiao; Paolo Boffetta
Journal:  Chin J Cancer Res       Date:  2012-03       Impact factor: 5.087

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.